Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions

NCT07316504 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT07316504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07316504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Not applicable
Overall status
Recruiting
Start date
October 22, 2025
Completion date
September 30, 2031
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

angioplasty, transluminal, percutaneous coronary, coronary angioplasty, coronary artery disease, coronary artery disease (cad), coronary stent restenosis, intravascular lithotripsy, intravascular lithotripsy; rotational atherectomy; ofdi, lithotripsy, oct angiography, optical coherence tomography (oct), percutaneous coronary intervention (pci), restenosis, restenosis of coronary artery stent